CDC Working to Maintain Yellow Fever Vaccine Supply

The virus is still found in tropical and subtropical areas in South America and Africa and remains a very rare cause of illness in U.S. travelers, according to CDC.

The Centers for Disease Control and Prevention has decided on a plan to ensure a continuous yellow fever vaccine supply in the United States as it anticipates the end of the U.S.-licensed YF-VAX® yellow fever vaccine in mid-2017. CDC outlined it in the issue of Morbidity and Mortality Weekly Report published on April 28.

In 2016, a manufacturing issue at Sanofi Pasteur limited the production of YF-VAX, and no yellow fever vaccine is expected to be available by the middle of 2017. YF-VAX is the only yellow fever vaccine licensed for use in the United States and is distributed to approximately 4,000 clinic sites.

Perhaps not thought of as a threat by most Americans who learned the disease's name in history classes, yellow fever was a scourge until doctors found it was caused by the bites of infected mosquitoes and vaccines were developed during the 1930s. The virus is still found in tropical and subtropical areas in South America and Africa and remains a very rare cause of illness in U.S. travelers, according to CDC. The illness ranges in severity from a self-limited febrile illness to severe liver disease with bleeding.

The MMWR article says in 2015, approximately 8 million U.S. residents traveled to 42 countries with endemic yellow fever virus transmission, and the reports of yellow fever in at least 10 unimmunized returning U.S. and European travelers were recorded during 1970-2013. Yellow fever virus was exported from Angola during the 2016 outbreak to three countries, and a current outbreak in Brazil has resulted in 681 confirmed cases from December 2016 through April 25, 2017.

The agency says it collaborated with Sanofi Pasteur on a plan to distribute limited quantities of Stamaril yellow fever vaccine to prevent people from becoming infected by the virus until production of YF-VAX resumes at a new facility in 2018. Stamaril is manufactured by Sanofi Pasteur in France and distributed in more than 70 countries; in October 2016, the U.S. Food and Drug Administration authorized an Expanded Access Investigational New Drug protocol that allows for the distribution of Stamaril to designated U.S. clinic sites until YF-VAX production resumes.

For yellow fever vaccine shortage and drug information, visit Sanofi Pasteur at http://www.sanofipasteur.us/vaccines/yellowfevervaccine.

Download Center

  • Hand Safety Program

    Hand injuries are the #1 preventable industrial accident worldwide. In REThinking Hand Safety, the most comprehensive book on hand safety, you'll learn how top companies have reduced hand injuries by up to 90% and what the most successful hand safety programs have in common. Get your free copy today!

  • Free 1-on-1 Consultations

    Is your company ready to reduce hand injuries? Schedule a free meeting with a Superior Glove hand safety expert and learn how to reduce hand injuries, lower PPE costs, and increase worker productivity. Our 1-on-1 consultations offer personalized advice and recommendations for your specific needs and concerns.

  • Glove 101 Guide

    Choosing the right safety gloves for your workers can be a daunting task. That’s where some basic knowledge of gloves can really come in handy! In this comprehensive guide you’ll find key information you need to know about safety gloves from types of gloves and materials to additives, treatments, safety standards, and more.

  • Sample Program

    Find the right safety gloves for your team and try before you buy—in just 3 easy steps! Simply add the products you want to try to your sample box, complete the sample request form, and wait for your samples to arrive at no cost to you.

  • Water Protection Product Guide

    Find the right safety gloves for your workers that are designed to protect in wet environments. From light and flexible to heavy duty, find the best water-resistant gloves with mechanical protection to safeguard workers.

  • Superior Glove

Featured Whitepaper

OH&S Digital Edition

  • OHS Magazine Digital Edition - November December 2022

    November December 2022

    Featuring:

    • IH: GAS DETECTION
      The Evolution of Gas Detection
    • OSHA TOP 10
      OSHA's Top 10 Most Frequently Cited Standards for FY 2022
    • FALL PROTECTION
      Enhance Your Fall Protection Program with Technology
    • 90TH ANNIVERSARY
      The Future: How Safety WIll Continue to Evolve
    View This Issue